May had been a busy month for PharmaShots with an unceasing influx of life science updates.  

In our most-read Top 20 section, we published reports on Diagnostic Companies and Medical Device Companies. 

Like every month, PharmaShots published reports on Key Biosimilars Events, FDA approvals, and EMA approvals along with the New Drug Designation Report. In the Disease of the Month report, we explored Sjögren’s syndrome. The May Edition of Know Your Investor featured Alexandria Venture Investment. 

As an annual custom, we published an analysis of the Growth of Biopharma Companies in the Last 20 years (2004-2023) 

A theme as diverse as MedTech can be hard to encompass in a single digest/magazine. For the subsequent two months, PharmaShots Magazine will be exploring MedTech as a field.  

To spice up the theme, PharmaShots decided to navigate the theme based on the US FDA’s classification of Medical Devices. This Month, we are focusing on Class I and Class II medical devices, and for the next month, our focus will be solely on Class III medical devices. 

Want to advertise in PharmaShots Magazine for FREE? Email us at connect@pharmashots.com